carnitine has been researched along with Breast Neoplasms in 17 studies
Breast Neoplasms: Tumors or cancer of the human BREAST.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This randomized trial investigated the efficacy of the amino acid jelly Inner Power(®) (IP), a semi-solid, orally administrable dietary supplement containing coenzyme Q10 and L-carnitine, in controlling CRF in breast cancer patients in Japan." | 9.22 | Efficacy and safety of an amino acid jelly containing coenzyme Q10 and L-carnitine in controlling fatigue in breast cancer patients receiving chemotherapy: a multi-institutional, randomized, exploratory trial (JORTC-CAM01). ( Ariyoshi, K; Doi, T; Inoue, K; Ishiki, H; Iwase, S; Kawaguchi, T; Kitamura, K; Miyaji, T; Miyara, K; Odagiri, H; Sagara, Y; Tsutsumi, C; Yamaguchi, T; Yotsumoto, D, 2016) |
| " This review illustrates the possible role of L-carnitine as an add-on therapy to breast cancer patients maintained on tamoxifen." | 8.90 | A review on the role of L-carnitine in the management of tamoxifen side effects in treated women with breast cancer. ( El-Ashmawy, NE; Khalil, RM, 2014) |
| " Here, we propose a mass spectrometry imaging (MSI)-based metabolomic strategy to visualize the spatially resolved reprogramming of carnitine metabolism in heterogeneous breast cancer." | 7.96 | Mass spectrometry imaging-based metabolomics to visualize the spatially resolved reprogramming of carnitine metabolism in breast cancer. ( Sun, C; Wang, F; Wang, X; Yu, J; Zhang, Y, 2020) |
| "To evaluate the levels of serum carnitine in patients with cancer in digestive organs and to compare them with other cancers in order to provide new insights into the mechanisms of cachexia." | 7.73 | Decrease of serum carnitine levels in patients with or without gastrointestinal cancer cachexia. ( Barone, G; Cannizzaro, MA; Costanzo, M; Gargante, MP; Malaguarnera, M; Oreste, G; Risino, C; Tomasello, AV, 2006) |
| "L-Carnitine is an essential co-factor for carrying long-chain fatty acids into the mitochondria." | 5.91 | Evaluation of the gene encoding carnitine transporter (OCTN2/SLC22A5) expression in human breast cancer and its association with clinicopathological characteristics. ( Azizi, R; Dinarvand, N; Karimi, F; Pourfarzam, M; Rastaghi, S; Sheikhi, A, 2023) |
| "Carnitine transport was positively correlated with the level of OCTN2 phosphorylated by AKT on threonine moiety." | 5.91 | The activity and surface presence of organic cation/carnitine transporter OCTN2 (SLC22A5) in breast cancer cells depends on AKT kinase. ( Jurewicz, E; Lamch, W; Nałęcz, KA; Papierniak-Wyglądała, A, 2023) |
| "Limonene is a lipophilic monoterpene found in high levels in citrus peel." | 5.42 | Plasma metabolomic profiles of breast cancer patients after short-term limonene intervention. ( Chow, HH; Hu, C; Keun, HC; Lang, JE; Miller, JA; Pappan, K; Siskos, AP; Thompson, PA; Want, EJ; Wulff, J, 2015) |
| " This randomized trial investigated the efficacy of the amino acid jelly Inner Power(®) (IP), a semi-solid, orally administrable dietary supplement containing coenzyme Q10 and L-carnitine, in controlling CRF in breast cancer patients in Japan." | 5.22 | Efficacy and safety of an amino acid jelly containing coenzyme Q10 and L-carnitine in controlling fatigue in breast cancer patients receiving chemotherapy: a multi-institutional, randomized, exploratory trial (JORTC-CAM01). ( Ariyoshi, K; Doi, T; Inoue, K; Ishiki, H; Iwase, S; Kawaguchi, T; Kitamura, K; Miyaji, T; Miyara, K; Odagiri, H; Sagara, Y; Tsutsumi, C; Yamaguchi, T; Yotsumoto, D, 2016) |
| " This review illustrates the possible role of L-carnitine as an add-on therapy to breast cancer patients maintained on tamoxifen." | 4.90 | A review on the role of L-carnitine in the management of tamoxifen side effects in treated women with breast cancer. ( El-Ashmawy, NE; Khalil, RM, 2014) |
| " Here, we propose a mass spectrometry imaging (MSI)-based metabolomic strategy to visualize the spatially resolved reprogramming of carnitine metabolism in heterogeneous breast cancer." | 3.96 | Mass spectrometry imaging-based metabolomics to visualize the spatially resolved reprogramming of carnitine metabolism in breast cancer. ( Sun, C; Wang, F; Wang, X; Yu, J; Zhang, Y, 2020) |
| "Associations between pre-diagnostic levels of 120 circulating metabolites (acylcarnitines, amino acids, biogenic amines, phosphatidylcholines, sphingolipids, and hexoses) and the risks of breast, prostate, and colorectal cancer were evaluated by Cox regression analyses using data of a prospective case-cohort study including 835 incident cancer cases." | 3.83 | Higher plasma levels of lysophosphatidylcholine 18:0 are related to a lower risk of common cancers in a prospective metabolomics study. ( Boeing, H; Floegel, A; Johnson, T; Kaaks, R; Kühn, T; Otto, W; Rolle-Kampczyk, U; Sookthai, D; von Bergen, M, 2016) |
| "To evaluate the levels of serum carnitine in patients with cancer in digestive organs and to compare them with other cancers in order to provide new insights into the mechanisms of cachexia." | 3.73 | Decrease of serum carnitine levels in patients with or without gastrointestinal cancer cachexia. ( Barone, G; Cannizzaro, MA; Costanzo, M; Gargante, MP; Malaguarnera, M; Oreste, G; Risino, C; Tomasello, AV, 2006) |
| "L-Carnitine is an essential co-factor for carrying long-chain fatty acids into the mitochondria." | 1.91 | Evaluation of the gene encoding carnitine transporter (OCTN2/SLC22A5) expression in human breast cancer and its association with clinicopathological characteristics. ( Azizi, R; Dinarvand, N; Karimi, F; Pourfarzam, M; Rastaghi, S; Sheikhi, A, 2023) |
| "Carnitine transport was positively correlated with the level of OCTN2 phosphorylated by AKT on threonine moiety." | 1.91 | The activity and surface presence of organic cation/carnitine transporter OCTN2 (SLC22A5) in breast cancer cells depends on AKT kinase. ( Jurewicz, E; Lamch, W; Nałęcz, KA; Papierniak-Wyglądała, A, 2023) |
| "Breast cancer is the commonest malignancy of women and with its incidence on the rise, the need to identify new targets for treatment is imperative." | 1.72 | The role of CPT1A as a biomarker of breast cancer progression: a bioinformatic approach. ( Das, M; Giannoudis, A; Sharma, V, 2022) |
| "Limonene is a lipophilic monoterpene found in high levels in citrus peel." | 1.42 | Plasma metabolomic profiles of breast cancer patients after short-term limonene intervention. ( Chow, HH; Hu, C; Keun, HC; Lang, JE; Miller, JA; Pappan, K; Siskos, AP; Thompson, PA; Want, EJ; Wulff, J, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.76) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 7 (41.18) | 24.3611 |
| 2020's | 5 (29.41) | 2.80 |
| Authors | Studies |
|---|---|
| Das, M | 1 |
| Giannoudis, A | 1 |
| Sharma, V | 1 |
| Qutob, HMH | 1 |
| Saad, RA | 1 |
| Bali, H | 1 |
| Osailan, A | 1 |
| Jaber, J | 1 |
| Alzahrani, E | 1 |
| Alyami, J | 1 |
| Elsayed, H | 1 |
| Alserihi, R | 1 |
| Shaikhomar, OA | 1 |
| Divya, KM | 1 |
| Savitha, DP | 1 |
| Krishna, GA | 1 |
| Dhanya, TM | 1 |
| Mohanan, PV | 1 |
| Shah, SF | 1 |
| Jafry, AT | 1 |
| Hussain, G | 1 |
| Kazim, AH | 1 |
| Ali, M | 1 |
| Rivani, E | 1 |
| Endraswari, PD | 1 |
| Widodo, ADW | 1 |
| Khalil, MR | 1 |
| Guldberg, R | 1 |
| Nørgård, BM | 1 |
| Uldbjerg, N | 1 |
| Wehberg, S | 1 |
| Fowobaje, KR | 1 |
| Mashood, LO | 1 |
| Ekholuenetale, M | 1 |
| Ibidoja, OJ | 1 |
| Romagnoli, A | 1 |
| D'Agostino, M | 1 |
| Pavoni, E | 1 |
| Ardiccioni, C | 1 |
| Motta, S | 1 |
| Crippa, P | 1 |
| Biagetti, G | 1 |
| Notarstefano, V | 1 |
| Rexha, J | 1 |
| Perta, N | 1 |
| Barocci, S | 1 |
| Costabile, BK | 1 |
| Colasurdo, G | 1 |
| Caucci, S | 1 |
| Mencarelli, D | 1 |
| Turchetti, C | 1 |
| Farina, M | 1 |
| Pierantoni, L | 1 |
| La Teana, A | 1 |
| Al Hadi, R | 1 |
| Cicconardi, F | 1 |
| Chinappi, M | 1 |
| Trucchi, E | 1 |
| Mancia, F | 1 |
| Menzo, S | 1 |
| Morozzo Della Rocca, B | 1 |
| D'Annessa, I | 1 |
| Di Marino, D | 1 |
| Choya, A | 1 |
| de Rivas, B | 1 |
| Gutiérrez-Ortiz, JI | 1 |
| López-Fonseca, R | 1 |
| Xu, S | 1 |
| Cheng, B | 1 |
| Huang, Z | 1 |
| Liu, T | 1 |
| Li, Y | 1 |
| Jiang, L | 2 |
| Guo, W | 1 |
| Xiong, J | 1 |
| Amirazodi, M | 1 |
| Daryanoosh, F | 1 |
| Mehrabi, A | 1 |
| Gaeini, A | 1 |
| Koushkie Jahromi, M | 1 |
| Salesi, M | 1 |
| Zarifkar, AH | 1 |
| Studeny, P | 1 |
| Netukova, M | 1 |
| Nemcokova, M | 1 |
| Klimesova, YM | 1 |
| Krizova, D | 1 |
| Kang, H | 1 |
| Tao, Y | 1 |
| Zhang, Q | 1 |
| Sha, D | 1 |
| Chen, Y | 1 |
| Yao, J | 1 |
| Gao, Y | 1 |
| Liu, J | 1 |
| Ji, L | 1 |
| Shi, P | 1 |
| Shi, C | 1 |
| Wu, YL | 1 |
| Wright, AI | 1 |
| M El-Metwaly, N | 1 |
| A Katouah, H | 1 |
| El-Desouky, MG | 1 |
| El-Bindary, AA | 1 |
| El-Bindary, MA | 1 |
| Kostakis, ID | 1 |
| Raptis, DA | 1 |
| Davidson, BR | 1 |
| Iype, S | 1 |
| Nasralla, D | 1 |
| Imber, C | 1 |
| Sharma, D | 1 |
| Pissanou, T | 1 |
| Pollok, JM | 1 |
| Hughes, AM | 1 |
| Sanderson, E | 1 |
| Morris, T | 1 |
| Ayorech, Z | 1 |
| Tesli, M | 1 |
| Ask, H | 1 |
| Reichborn-Kjennerud, T | 1 |
| Andreassen, OA | 1 |
| Magnus, P | 1 |
| Helgeland, Ø | 1 |
| Johansson, S | 1 |
| Njølstad, P | 1 |
| Davey Smith, G | 1 |
| Havdahl, A | 1 |
| Howe, LD | 1 |
| Davies, NM | 1 |
| Amrillah, T | 1 |
| Prasetio, A | 1 |
| Supandi, AR | 1 |
| Sidiq, DH | 1 |
| Putra, FS | 1 |
| Nugroho, MA | 1 |
| Salsabilla, Z | 1 |
| Azmi, R | 1 |
| Grammatikopoulos, P | 1 |
| Bouloumis, T | 1 |
| Steinhauer, S | 1 |
| Mironov, VS | 2 |
| Bazhenova, TA | 2 |
| Manakin, YV | 2 |
| Yagubskii, EB | 2 |
| Yakushev, IA | 1 |
| Gilmutdinov, IF | 1 |
| Simonov, SV | 1 |
| Lan, K | 1 |
| Yang, H | 1 |
| Zheng, J | 1 |
| Hu, H | 1 |
| Zhu, T | 1 |
| Zou, X | 1 |
| Hu, B | 1 |
| Liu, H | 1 |
| Olokede, O | 1 |
| Wu, H | 1 |
| Holtzapple, M | 1 |
| Gungor, O | 1 |
| Kose, M | 1 |
| Ghaemi, R | 1 |
| Acker, M | 1 |
| Stosic, A | 1 |
| Jacobs, R | 1 |
| Selvaganapathy, PR | 1 |
| Ludwig, N | 1 |
| Yerneni, SS | 1 |
| Azambuja, JH | 1 |
| Pietrowska, M | 1 |
| Widłak, P | 1 |
| Hinck, CS | 1 |
| Głuszko, A | 1 |
| Szczepański, MJ | 1 |
| Kärmer, T | 1 |
| Kallinger, I | 1 |
| Schulz, D | 1 |
| Bauer, RJ | 1 |
| Spanier, G | 1 |
| Spoerl, S | 1 |
| Meier, JK | 1 |
| Ettl, T | 1 |
| Razzo, BM | 1 |
| Reichert, TE | 1 |
| Hinck, AP | 1 |
| Whiteside, TL | 1 |
| Wei, ZL | 1 |
| Juan, W | 1 |
| Tong, D | 1 |
| Juan, LX | 1 |
| Sa, LY | 1 |
| Jie, HFM | 1 |
| Xiao, G | 1 |
| Xiang, LG | 1 |
| Jie, HM | 1 |
| Xu, C | 1 |
| Yu, DN | 1 |
| Yao, ZX | 1 |
| Bigdeli, F | 1 |
| Gao, XM | 1 |
| Cheng, X | 1 |
| Li, JZ | 1 |
| Zhang, JW | 1 |
| Wang, W | 2 |
| Guan, ZJ | 1 |
| Bu, Y | 1 |
| Liu, KG | 1 |
| Morsali, A | 1 |
| Das, R | 1 |
| Paul, R | 1 |
| Parui, A | 1 |
| Shrotri, A | 1 |
| Atzori, C | 1 |
| Lomachenko, KA | 1 |
| Singh, AK | 1 |
| Mondal, J | 1 |
| Peter, SC | 1 |
| Florimbio, AR | 1 |
| Coughlin, LN | 1 |
| Bauermeister, JA | 1 |
| Young, SD | 1 |
| Zimmerman, MA | 1 |
| Walton, MA | 1 |
| Bonar, EE | 1 |
| Demir, D | 1 |
| Balci, AB | 1 |
| Kahraman, N | 1 |
| Sunbul, SA | 1 |
| Gucu, A | 1 |
| Seker, IB | 1 |
| Badem, S | 1 |
| Yuksel, A | 1 |
| Ozyazicioglu, AF | 1 |
| Goncu, MT | 1 |
| Zhang, H | 1 |
| Zhou, H | 1 |
| Deng, Z | 1 |
| Luo, L | 1 |
| Ong, SP | 1 |
| Wang, C | 2 |
| Xin, H | 1 |
| Whittingham, MS | 1 |
| Zhou, G | 1 |
| Maemura, R | 1 |
| Wakamatsu, M | 1 |
| Matsumoto, K | 1 |
| Sakaguchi, H | 1 |
| Yoshida, N | 1 |
| Hama, A | 1 |
| Yoshida, T | 1 |
| Miwata, S | 1 |
| Kitazawa, H | 1 |
| Narita, K | 1 |
| Kataoka, S | 1 |
| Ichikawa, D | 1 |
| Hamada, M | 1 |
| Taniguchi, R | 1 |
| Suzuki, K | 1 |
| Kawashima, N | 1 |
| Nishikawa, E | 1 |
| Narita, A | 1 |
| Okuno, Y | 1 |
| Nishio, N | 1 |
| Kato, K | 1 |
| Kojima, S | 1 |
| Morita, K | 1 |
| Muramatsu, H | 1 |
| Takahashi, Y | 1 |
| Yirgu, A | 1 |
| Mekonnen, Y | 1 |
| Eyado, A | 1 |
| Staropoli, A | 1 |
| Vinale, F | 1 |
| Zac, J | 1 |
| Zac, S | 1 |
| Pérez-Padilla, R | 1 |
| Remigio-Luna, A | 1 |
| Guzmán-Boulloud, N | 1 |
| Gochicoa-Rangel, L | 1 |
| Guzmán-Valderrábano, C | 1 |
| Thirión-Romero, I | 1 |
| Statsenko, ME | 1 |
| Turkina, SV | 1 |
| Barantsevich, ER | 1 |
| Karakulova, YV | 1 |
| Baranova, NS | 1 |
| Morzhukhina, MV | 1 |
| Wang, Q | 1 |
| Gu, Y | 1 |
| Chen, C | 1 |
| Qiao, L | 1 |
| Pan, F | 1 |
| Song, C | 1 |
| Canetto, SS | 1 |
| Entilli, L | 1 |
| Cerbo, I | 1 |
| Cipolletta, S | 1 |
| Wu, Y | 2 |
| Zhu, P | 1 |
| Jiang, Y | 1 |
| Zhang, X | 1 |
| Wang, Z | 1 |
| Xie, B | 1 |
| Song, T | 1 |
| Zhang, F | 1 |
| Luo, A | 1 |
| Li, S | 1 |
| Xiong, X | 1 |
| Han, J | 1 |
| Peng, X | 1 |
| Li, M | 1 |
| Huang, L | 1 |
| Chen, Q | 1 |
| Fang, W | 1 |
| Hou, Y | 1 |
| Zhu, Y | 1 |
| Ye, J | 1 |
| Liu, L | 1 |
| Islam, MR | 1 |
| Sanderson, P | 1 |
| Johansen, MP | 1 |
| Payne, TE | 1 |
| Naidu, R | 1 |
| Cao, J | 1 |
| Yang, J | 1 |
| Niu, X | 1 |
| Liu, X | 1 |
| Zhai, Y | 1 |
| Qiang, C | 1 |
| Niu, Y | 1 |
| Li, Z | 1 |
| Dong, N | 1 |
| Wen, B | 1 |
| Ouyang, Z | 1 |
| Zhang, Y | 2 |
| Li, J | 2 |
| Zhao, M | 1 |
| Zhao, J | 1 |
| Morici, P | 1 |
| Rizzato, C | 1 |
| Ghelardi, E | 1 |
| Rossolini, GM | 1 |
| Lupetti, A | 1 |
| Gözüküçük, R | 1 |
| Cakiroglu, B | 1 |
| He, X | 1 |
| Li, R | 1 |
| Zhao, D | 1 |
| Zhang, L | 1 |
| Ji, X | 1 |
| Fan, X | 1 |
| Chen, J | 1 |
| Wang, Y | 1 |
| Luo, Y | 1 |
| Zheng, D | 1 |
| Xie, L | 1 |
| Sun, S | 1 |
| Cai, Z | 1 |
| Liu, Q | 1 |
| Ma, K | 1 |
| Sun, X | 1 |
| Drinkwater, JJ | 1 |
| Davis, TME | 1 |
| Turner, AW | 1 |
| Davis, WA | 1 |
| Suzuki, Y | 1 |
| Mizuta, Y | 1 |
| Mikagi, A | 1 |
| Misawa-Suzuki, T | 1 |
| Tsuchido, Y | 1 |
| Sugaya, T | 1 |
| Hashimoto, T | 1 |
| Ema, K | 1 |
| Hayashita, T | 1 |
| Dinarvand, N | 1 |
| Karimi, F | 1 |
| Azizi, R | 1 |
| Rastaghi, S | 1 |
| Sheikhi, A | 1 |
| Pourfarzam, M | 1 |
| Papierniak-Wyglądała, A | 1 |
| Lamch, W | 1 |
| Jurewicz, E | 1 |
| Nałęcz, KA | 1 |
| Park, J | 1 |
| Shin, Y | 1 |
| Kim, TH | 1 |
| Kim, DH | 1 |
| Lee, A | 1 |
| Sun, C | 1 |
| Wang, F | 1 |
| Yu, J | 1 |
| Wang, X | 1 |
| El-Ashmawy, NE | 1 |
| Khalil, RM | 1 |
| Miller, JA | 1 |
| Pappan, K | 1 |
| Thompson, PA | 1 |
| Want, EJ | 1 |
| Siskos, AP | 1 |
| Keun, HC | 1 |
| Wulff, J | 1 |
| Hu, C | 1 |
| Lang, JE | 1 |
| Chow, HH | 1 |
| Iwase, S | 1 |
| Kawaguchi, T | 1 |
| Yotsumoto, D | 1 |
| Doi, T | 1 |
| Miyara, K | 1 |
| Odagiri, H | 1 |
| Kitamura, K | 1 |
| Ariyoshi, K | 1 |
| Miyaji, T | 1 |
| Ishiki, H | 1 |
| Inoue, K | 1 |
| Tsutsumi, C | 1 |
| Sagara, Y | 1 |
| Yamaguchi, T | 1 |
| Kühn, T | 1 |
| Floegel, A | 1 |
| Sookthai, D | 1 |
| Johnson, T | 1 |
| Rolle-Kampczyk, U | 1 |
| Otto, W | 1 |
| von Bergen, M | 1 |
| Boeing, H | 1 |
| Kaaks, R | 1 |
| Uray, IP | 1 |
| Mazumdar, A | 1 |
| Mayer, JA | 1 |
| Brown, PH | 1 |
| Chughtai, K | 1 |
| Greenwood, TR | 1 |
| Glunde, K | 1 |
| Heeren, RM | 1 |
| Shennan, DB | 1 |
| Malaguarnera, M | 1 |
| Risino, C | 1 |
| Gargante, MP | 1 |
| Oreste, G | 1 |
| Barone, G | 1 |
| Tomasello, AV | 1 |
| Costanzo, M | 1 |
| Cannizzaro, MA | 1 |
| Delaney, CE | 1 |
| Hopkins, SP | 1 |
| Addison, CL | 1 |
| Van Hinsbergh, VW | 1 |
| Veerkamp, JH | 1 |
| Van Moerkerk, HT | 1 |
| De Leonardis, V | 1 |
| De Scalzi, M | 1 |
| Neri, B | 1 |
| Bartalucci, S | 1 |
| Cinelli, P | 1 |
2 reviews available for carnitine and Breast Neoplasms
| Article | Year |
|---|---|
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter | 2022 |
A review on the role of L-carnitine in the management of tamoxifen side effects in treated women with breast cancer.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Carnitine; Female; Humans; Insulin-Like Growth Fa | 2014 |
2 trials available for carnitine and Breast Neoplasms
| Article | Year |
|---|---|
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter | 2022 |
Efficacy and safety of an amino acid jelly containing coenzyme Q10 and L-carnitine in controlling fatigue in breast cancer patients receiving chemotherapy: a multi-institutional, randomized, exploratory trial (JORTC-CAM01).
Topics: Adult; Aged; Breast Neoplasms; Carnitine; Fatigue; Female; Humans; Middle Aged; Quality of Life; Ubi | 2016 |
14 other studies available for carnitine and Breast Neoplasms
| Article | Year |
|---|---|
The role of CPT1A as a biomarker of breast cancer progression: a bioinformatic approach.
Topics: Biomarkers; Breast Neoplasms; Carnitine; Carnitine O-Palmitoyltransferase; Computational Biology; Ep | 2022 |
Evaluation of the gene encoding carnitine transporter (OCTN2/SLC22A5) expression in human breast cancer and its association with clinicopathological characteristics.
Topics: Breast Neoplasms; Carnitine; Fatty Acids; Female; Humans; Organic Cation Transport Proteins; Solute | 2023 |
The activity and surface presence of organic cation/carnitine transporter OCTN2 (SLC22A5) in breast cancer cells depends on AKT kinase.
Topics: Breast Neoplasms; Carnitine; Cations; Female; Humans; Organic Cation Transport Proteins; Proto-Oncog | 2023 |
Plasma metabolites as possible biomarkers for diagnosis of breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; Carnitine; Case-Control Studies | 2019 |
Mass spectrometry imaging-based metabolomics to visualize the spatially resolved reprogramming of carnitine metabolism in breast cancer.
Topics: Adult; Aged; Animals; Biomarkers, Tumor; Breast; Breast Neoplasms; Carnitine; Carnitine O-Acetyltran | 2020 |
Plasma metabolomic profiles of breast cancer patients after short-term limonene intervention.
Topics: Amino Acids; Anticarcinogenic Agents; Antineoplastic Agents; Bile Acids and Salts; Breast Neoplasms; | 2015 |
Higher plasma levels of lysophosphatidylcholine 18:0 are related to a lower risk of common cancers in a prospective metabolomics study.
Topics: Biomarkers, Tumor; Breast Neoplasms; Carnitine; Cohort Studies; Colorectal Neoplasms; Female; Humans | 2016 |
SLC22A5/OCTN2 expression in breast cancer is induced by estrogen via a novel intronic estrogen-response element (ERE).
Topics: Base Sequence; Binding Sites; Breast Neoplasms; Carnitine; Cell Line, Tumor; Cell Proliferation; Est | 2012 |
Mass spectrometry images acylcarnitines, phosphatidylcholines, and sphingomyelin in MDA-MB-231 breast tumor models.
Topics: Animals; Breast Neoplasms; Carnitine; Cell Line, Tumor; Cell Transformation, Neoplastic; Humans; Mas | 2013 |
Hyposmotically-activated efflux of L-carnitine from a human mammary cancer cell line.
Topics: Biological Transport; Breast Neoplasms; Carnitine; Female; Humans; Osmolar Concentration; Salicylate | 2001 |
Decrease of serum carnitine levels in patients with or without gastrointestinal cancer cachexia.
Topics: Adult; Breast Neoplasms; Cachexia; Carnitine; Case-Control Studies; Diet; Disease Progression; Femal | 2006 |
Supplementation with l-carnitine does not reduce the efficacy of epirubicin treatment in breast cancer cells.
Topics: Antibiotics, Antineoplastic; Base Sequence; Blotting, Western; Breast Neoplasms; Carnitine; Cell Lin | 2007 |
Cytochrome c oxidase activity and fatty acid oxidation in various types of human muscle.
Topics: Animals; Breast Neoplasms; Carnitine; Electron Transport Complex IV; Fatty Acids; Female; Humans; Ki | 1980 |
Echocardiographic assessment of anthracycline cardiotoxicity during different therapeutic regimens.
Topics: Adult; Breast Neoplasms; Carnitine; Doxorubicin; Echocardiography; Epirubicin; Female; Heart Disease | 1987 |